MicroCyto Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$220M
- Investors
-
16
MicroCyto General Information
Description
Manufacturer and Developer of biotechnology solutions intended for human and animal nutrition, and chemical materials. The company's products mainly focus on synthetic biotechnology and commit to using low-carbon, energy-saving, and sustainable methods to produce various compounds for use in medicine, daily chemicals, agriculture, food, feed, and materials, and other fields, providing customers with reliable and efficient products.
Contact Information
Website
www.microcyto.cnCorporate Office
- Room C223-4, 2nd Floor, Building 2, Number 9, Yike Road
- Life Science Park, Changping District
- Beijing, 102200
- China
Corporate Office
- Room C223-4, 2nd Floor, Building 2, Number 9, Yike Road
- Life Science Park, Changping District
- Beijing, 102200
- China
MicroCyto Timeline
MicroCyto Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 13-May-2026 | $220M | Completed | Generating Revenue | ||
| 5. Early Stage VC (Series A1) | 04-Jan-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 29-Aug-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 16-Aug-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 15-Jun-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 30-May-2022 | Completed | Startup |
MicroCyto Patents
MicroCyto Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026219236-A1 | Multi-site chromosome editing tool and use thereof | Pending | 16-Apr-2025 | ||
| WO-2026039994-A1 | Recombinant escherichia coli for producing d-psicose, and preparation method therefor | Pending | 20-Aug-2024 |
MicroCyto Signals
MicroCyto Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Zhongguancun Capital Fund Management | Growth/Expansion | Minority | ||
| Jianxin Financial Asset Investment | Asset Manager | Minority | ||
| Beijing Qijian Private Equity Fund Management | Growth/Expansion | Minority | ||
| Beijing State-owned Capital Operation and Management | Government | Minority | ||
| Shenzhen Capital Group | Venture Capital | Minority |
MicroCyto FAQs
-
When was MicroCyto founded?
MicroCyto was founded in 2021.
-
Where is MicroCyto headquartered?
MicroCyto is headquartered in Beijing, China.
-
What is the size of MicroCyto?
MicroCyto has 100 total employees.
-
What industry is MicroCyto in?
MicroCyto’s primary industry is Multi-line Chemicals.
-
Is MicroCyto a private or public company?
MicroCyto is a Private company.
-
What is MicroCyto’s current revenue?
The current revenue for MicroCyto is .
-
How much funding has MicroCyto raised over time?
MicroCyto has raised $306M.
-
Who are MicroCyto’s investors?
Beijing Zhongguancun Capital Fund Management, Jianxin Financial Asset Investment, Beijing Qijian Private Equity Fund Management, Beijing State-owned Capital Operation and Management, and Shenzhen Capital Group are 5 of 16 investors who have invested in MicroCyto.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process